GH reports research grants from the Netherlands Organization for Scientific Research (vidi 016.156.445), CardioVascular Research Initiative, European Union and the Klinkerpad fonds, institutional research support from Aegerion, Amgen, AstraZeneca, Eli Lilly, Genzyme, Ionis, Kowa, Pfizer, Regeneron, Roche, Sanofi, and The Medicines Company
Oct 6: People with a range of rheumatic diseases have a new treatment delivery option after the FDA approved an intravenous formulation of Novartis IL-17A antagonist Cosentyx (secukinumab)
Purpose and Medical Goals The primary goal of developing Semaglutide was to improve blood sugar control and aid in weight loss for individuals with type 2 diabetes
CAR-T cells directly engage with and eradicate cancer cells, effectively countering the immune evasion strategies utilized by malignant cells
Does Semaglutide need to stay cold during travel
The patent for Tirzepatide is expected to expire around 2026